VAERS reports by lot

GSK Hepatitis A lot B39CM: VAERS reports

26 VAERS reports list lot B39CM as a GSK Hepatitis A vaccine, received between 2017-09-01 and 2019-12-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
8%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1925%
Musculoskeletal1317%
General / Systemic (non-local)1216%
Gastrointestinal1013%
Dermatological (non-injection-site)79%
Injection-site / Local reaction68%
Allergic / Anaphylactic34%
Respiratory34%
Cardiac / Cardiovascular23%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Oregon4
Texas3
Florida3
Michigan2
Nebraska2
Maryland2
California1
Wisconsin1
Washington1
South Carolina1
Utah1
Alaska1

Reports by month received

2017-091
2017-103
2017-112
2017-123
2018-011
2018-021
2018-035
2018-051
2018-063
2018-072
2019-021
2019-061
2019-071
2019-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.